Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with high androgen levels may have more severe COVID-19 symptoms.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

COVID-19 may harm male fertility and damage the reproductive system.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.